0 XP   0   0   0

Anteo Diagnostics Ltd










Financial Health of Anteo Diagnostics Ltd




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Richest
#896 / 1193

Total Sales
#606 / 1193

Making Money
#447 / 1193

Working Efficiently
#907 / 1193

Anteo Diagnostics Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Anteo Diagnostics Ltd?

I guess you are interested in Anteo Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Anteo Diagnostics Ltd

Let's start. I'm going to help you getting a better view of Anteo Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Anteo Diagnostics Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Anteo Diagnostics Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Anteo Diagnostics Ltd. The closing price on 2022-11-25 was A$0.055 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Anteo Diagnostics Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Anteo Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Anteo Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,757.1% means that $-17.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -1,757.1%. The company is making a huge loss. -2
  • The TTM is -698.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,757.1%TTM-698.6%-1,058.6%
TTM-698.6%YOY-665.1%-33.5%
TTM-698.6%5Y-1,124.5%+425.9%
5Y-1,124.5%10Y-987.3%-137.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,757.1%-223.6%-1,533.5%
TTM-698.6%-281.7%-416.9%
YOY-665.1%-344.8%-320.3%
5Y-1,124.5%-450.1%-674.4%
10Y-987.3%-541.0%-446.3%
1.1.2. Return on Assets

Shows how efficient Anteo Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -45.2% Return on Assets means that Anteo Diagnostics Ltd generated $-0.45 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anteo Diagnostics Ltd:

  • The MRQ is -45.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.2%TTM-15.9%-29.3%
TTM-15.9%YOY-15.3%-0.7%
TTM-15.9%5Y-18.6%+2.6%
5Y-18.6%10Y-14.8%-3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.2%-9.9%-35.3%
TTM-15.9%-8.9%-7.0%
YOY-15.3%-9.3%-6.0%
5Y-18.6%-11.7%-6.9%
10Y-14.8%-12.7%-2.1%
1.1.3. Return on Equity

Shows how efficient Anteo Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -55.8% Return on Equity means Anteo Diagnostics Ltd generated $-0.56 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anteo Diagnostics Ltd:

  • The MRQ is -55.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-55.8%TTM-19.1%-36.7%
TTM-19.1%YOY-17.7%-1.5%
TTM-19.1%5Y-21.8%+2.6%
5Y-21.8%10Y-20.3%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.8%-12.0%-43.8%
TTM-19.1%-11.5%-7.6%
YOY-17.7%-10.8%-6.9%
5Y-21.8%-14.2%-7.6%
10Y-20.3%-15.2%-5.1%

1.2. Operating Efficiency of Anteo Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anteo Diagnostics Ltd is operating .

  • Measures how much profit Anteo Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -878.8% means the company generated $-8.79  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -878.8%. The company is operating very inefficient. -2
  • The TTM is -349.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-878.8%TTM-349.4%-529.4%
TTM-349.4%YOY-447.0%+97.6%
TTM-349.4%5Y-924.2%+574.8%
5Y-924.2%10Y-464.9%-459.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-878.8%-207.3%-671.5%
TTM-349.4%-271.0%-78.4%
YOY-447.0%-325.9%-121.1%
5Y-924.2%-454.0%-470.2%
10Y-464.9%-537.1%+72.2%
1.2.2. Operating Ratio

Measures how efficient Anteo Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.987-1.987
TTM-5Y5.568-5.568
5Y5.56810Y8.184-2.617
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY1.9873.604-1.617
5Y5.5685.132+0.436
10Y8.1846.371+1.813

1.3. Liquidity of Anteo Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.70 means the company has $6.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 6.700. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.547. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.700TTM13.547-6.846
TTM13.547YOY14.152-0.605
TTM13.5475Y10.672+2.875
5Y10.67210Y6.222+4.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7005.117+1.583
TTM13.5475.755+7.792
YOY14.1525.854+8.298
5Y10.6726.511+4.161
10Y6.2226.2220.000
1.3.2. Quick Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 6.54 means the company can pay off $6.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 6.543. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.865. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.543TTM6.865-0.321
TTM6.865YOY7.122-0.258
TTM6.8655Y5.271+1.594
5Y5.27110Y3.605+1.666
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5434.284+2.259
TTM6.8654.664+2.201
YOY7.1224.787+2.335
5Y5.2715.218+0.053
10Y3.6055.182-1.577

1.4. Solvency of Anteo Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anteo Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anteo Diagnostics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Anteo Diagnostics Ltd assets are financed with 19.1% credit (debt) and the remaining percentage (100% - 19.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.191. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.129. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.129+0.062
TTM0.129YOY0.131-0.002
TTM0.1295Y0.138-0.009
5Y0.13810Y0.222-0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.278-0.087
TTM0.1290.277-0.148
YOY0.1310.306-0.175
5Y0.1380.367-0.229
10Y0.2220.403-0.181
1.4.2. Debt to Equity Ratio

Measures if Anteo Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.5% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.235. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.150. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.150+0.085
TTM0.150YOY0.152-0.002
TTM0.1505Y0.163-0.013
5Y0.16310Y0.707-0.544
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.315-0.080
TTM0.1500.317-0.167
YOY0.1520.319-0.167
5Y0.1630.403-0.240
10Y0.7070.462+0.245

2. Market Valuation of Anteo Diagnostics Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anteo Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A PE ratio of -37.48 means the investor is paying $-37.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -31.714. Company is losing money. -2
  • The MRQ is -37.480. Company is losing money. -2
  • The TTM is -173.480. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-31.714MRQ-37.480+5.766
MRQ-37.480TTM-173.480+136.000
TTM-173.480YOY-231.061+57.581
TTM-173.4805Y-102.774-70.706
5Y-102.77410Y-159.154+56.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-31.714-8.986-22.728
MRQ-37.480-9.792-27.688
TTM-173.480-16.243-157.237
YOY-231.061-20.876-210.185
5Y-102.774-16.665-86.109
10Y-159.154-14.732-144.422

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Anteo Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.46 means the investor is paying $10.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is 8.849. Seems overpriced? -1
  • The MRQ is 10.458. Seems overpriced? -1
  • The TTM is 20.049. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD8.849MRQ10.458-1.609
MRQ10.458TTM20.049-9.591
TTM20.049YOY47.000-26.951
TTM20.0495Y18.669+1.380
5Y18.66910Y22.913-4.244
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.8491.835+7.014
MRQ10.4582.006+8.452
TTM20.0492.774+17.275
YOY47.0003.453+43.547
5Y18.6692.713+15.956
10Y22.9132.402+20.511
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anteo Diagnostics Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anteo Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.001-64%0.002-235%0.000-2410%0.000-3299%
Book Value Growth---0.0060.217-103%0.525-101%0.304-102%0.302-102%
Book Value Per Share--0.0060.009-30%0.005+35%0.004+64%0.004+76%
Book Value Per Share Growth---0.491-0.159-68%0.297-265%-0.032-94%-0.033-93%
Current Ratio--6.70013.547-51%14.152-53%10.672-37%6.222+8%
Debt To Asset Ratio--0.1910.129+48%0.131+46%0.138+38%0.222-14%
Debt To Equity Ratio--0.2350.150+57%0.152+55%0.163+45%0.707-67%
Dividend Per Share----0%-0%-0%-0%
Eps---0.002-0.001-22%-0.001-55%-0.001-56%-0.001-64%
Eps Growth----0.0510%-0.0790%0.313-100%0.143-100%
Gross Profit Margin--1.0000.500+100%0.774+29%0.881+13%1.135-12%
Net Profit Margin---17.571-6.986-60%-6.651-62%-11.245-36%-9.873-44%
Operating Margin---8.788-3.494-60%-4.470-49%-9.242+5%-4.649-47%
Operating Ratio----0%1.987-100%5.568-100%8.184-100%
Pb Ratio8.849-18%10.45820.049-48%47.000-78%18.669-44%22.913-54%
Pe Ratio-31.714+15%-37.480-173.480+363%-231.061+516%-102.774+174%-159.154+325%
Price Per Share0.055-18%0.0650.186-65%0.173-62%0.081-20%0.081-20%
Price To Total Gains Ratio-18.029+15%-21.307-123.185+478%52.244-141%-3526150.496+16549422%-1485991.722+6974206%
Profit Growth---100.000-100.0000%-65.506-34%-39.222-61%-37.202-63%
Quick Ratio--6.5436.865-5%7.122-8%5.271+24%3.605+82%
Return On Assets---0.452-0.159-65%-0.153-66%-0.186-59%-0.148-67%
Return On Equity---0.558-0.191-66%-0.177-68%-0.218-61%-0.203-64%
Revenue Growth--1.0001.0000%0.744+34%0.194+415%-0.437+144%
Total Gains Per Share---0.003-0.001-64%0.002-235%0.000-2410%0.000-3299%
Total Gains Per Share Growth---1.000-1.0000%1.000-200%90878.177-100%39213.235-100%
Usd Book Value--8341004.97111866348.986-30%6186769.816+35%5090816.392+64%4730232.286+76%
Usd Book Value Change Per Share---0.002-0.001-64%0.002-235%0.000-2410%0.000-3299%
Usd Book Value Per Share--0.0040.006-30%0.003+35%0.003+64%0.002+76%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001-22%-0.001-55%-0.001-56%0.000-64%
Usd Price Per Share0.037-18%0.0440.126-65%0.116-62%0.055-20%0.055-20%
Usd Profit---4654956.271-1808729.608-61%-1180957.620-75%-946183.932-80%-862842.015-81%
Usd Revenue--264915.991128417.522+106%164203.012+61%99872.218+165%308600.365-14%
Usd Total Gains Per Share---0.002-0.001-64%0.002-235%0.000-2410%0.000-3299%
 EOD+3 -2MRQTTM+5 -22YOY+9 -225Y+12 -2010Y+12 -20

4.2. Fundamental Score

Let's check the fundamental score of Anteo Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-31.714
Price to Book Ratio (EOD)Between0-18.849
Net Profit Margin (MRQ)Greater than0-17.571
Operating Margin (MRQ)Greater than0-8.788
Quick Ratio (MRQ)Greater than16.543
Current Ratio (MRQ)Greater than16.700
Debt to Asset Ratio (MRQ)Less than10.191
Debt to Equity Ratio (MRQ)Less than10.235
Return on Equity (MRQ)Greater than0.15-0.558
Return on Assets (MRQ)Greater than0.05-0.452
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.565
Ma 20Greater thanMa 500.051
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.059
OpenGreater thanClose0.051
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets15,264
Total Liabilities2,909
Total Stockholder Equity12,355
 As reported
Total Liabilities 2,909
Total Stockholder Equity+ 12,355
Total Assets = 15,264

Assets

Total Assets15,264
Total Current Assets10,826
Long-term Assets10,826
Total Current Assets
Cash And Cash Equivalents 10,103
Net Receivables 469
Other Current Assets 254
Total Current Assets  (as reported)10,826
Total Current Assets  (calculated)10,826
+/-0
Long-term Assets
Property Plant Equipment 4,015
Other Assets 423
Long-term Assets  (as reported)4,438
Long-term Assets  (calculated)4,438
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,616
Long-term Liabilities1,293
Total Stockholder Equity12,355
Total Current Liabilities
Short-term Debt 258
Accounts payable 704
Other Current Liabilities 655
Total Current Liabilities  (as reported)1,616
Total Current Liabilities  (calculated)1,616
+/-0
Long-term Liabilities
Long term Debt Total 776
Other Liabilities 517
Long-term Liabilities  (as reported)1,293
Long-term Liabilities  (calculated)1,293
+/- 0
Total Stockholder Equity
Common Stock87,454
Retained Earnings -78,362
Other Stockholders Equity 3,263
Total Stockholder Equity (as reported)12,355
Total Stockholder Equity (calculated)12,355
+/-0
Other
Capital Stock87,454
Cash and Short Term Investments 10,103
Common Stock Shares Outstanding 1,987,875
Liabilities and Stockholders Equity 15,264
Net Debt -9,070
Net Invested Capital 12,355
Net Tangible Assets 12,355
Net Working Capital 9,211
Short Long Term Debt Total 1,033



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
0
0
0
0
0
7,933
7,933
7,494
7,494
11,528
11,527
15,450
15,450
7,971
7,971
8,079
8,079
5,037
5,037
5,285
5,285
3,435
3,435
1,723
1,723
732
732
0
4,446
1,909
1,909
1,452
1,452
1,959
1,959
1,310
1,310
3,472
3,472
2,113
2,113
1,332
1,332
1,426
1,426
1,723
1,723
2,522
2,522
7,285
7,285
5,872
5,872
5,211
5,211
4,555
4,555
3,275
3,275
7,955
7,955
7,667
7,667
7,662
7,662
6,043
6,043
6,009
6,397
35,236
52,599
35,682
35,682
30,833
45,814
5,350
5,350
4,470
4,470
2,983
2,983
4,768
4,768
3,976
3,976
0
3,909
0
6,990
0
23,675
0
20,661
0
15,264
15,264020,661023,67506,99003,90903,9763,9764,7684,7682,9832,9834,4704,4705,3505,35045,81430,83335,68235,68252,59935,2366,3976,0096,0436,0437,6627,6627,6677,6677,9557,9553,2753,2754,5554,5555,2115,2115,8725,8727,2857,2852,5222,5221,7231,7231,4261,4261,3321,3322,1132,1133,4723,4721,3101,3101,9591,9591,4521,4521,9091,9094,44607327321,7231,7233,4353,4355,2855,2855,0375,0378,0798,0797,9717,97115,45015,45011,52711,5287,4947,4947,9337,93300000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
6,470
0
0
0
5,172
0
0
0
3,317
0
0
0
2,567
0
0
0
542
0
0
0
1,428
0
0
0
1,483
0
0
0
3,260
0
0
0
1,031
0
0
0
1,481
0
0
0
7,003
0
0
0
4,929
0
0
0
3,024
0
0
0
7,314
0
0
0
5,503
0
0
0
16,365
11,735
11,735
30,577
45,433
5,037
5,037
4,191
4,191
2,594
2,594
4,456
4,456
3,241
3,241
3,378
3,378
6,518
6,518
21,789
21,789
17,030
17,030
10,826
10,826
10,82610,82617,03017,03021,78921,7896,5186,5183,3783,3783,2413,2414,4564,4562,5942,5944,1914,1915,0375,03745,43330,57711,73511,73516,3650005,5030007,3140003,0240004,9290007,0030001,4810001,0310003,2600001,4830001,4280005420002,5670003,3170005,1720006,4700000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
5,568
0
0
0
3,764
0
0
0
1,247
0
0
0
422
0
0
0
297
0
0
0
1,294
0
0
0
1,281
0
0
0
3,121
0
0
0
953
0
0
0
1,426
0
0
0
6,864
0
0
0
4,883
0
0
0
2,621
0
0
0
7,071
0
0
0
5,207
0
0
0
3,765
2,331
2,331
642
1,062
4,919
4,919
3,329
3,329
2,301
2,301
4,276
4,276
2,112
2,112
0
3,215
0
6,434
0
21,392
0
16,614
0
10,103
10,103016,614021,39206,43403,21502,1122,1124,2764,2762,3012,3013,3293,3294,9194,9191,0626422,3312,3313,7650005,2070007,0710002,6210004,8830006,8640001,4260009530003,1210001,2810001,2940002970004220001,2470003,7640005,5680000000000
       Net Receivables 
0
0
0
0
0
0
0
144
144
69
92
129
129
509
514
2,153
2,153
864
870
911
911
624
624
173
173
1
1
0
155
128
128
27
27
173
173
165
165
138
138
41
41
76
76
67
67
53
53
637
637
137
137
31
31
43
43
43
43
402
402
128
128
234
234
142
142
243
243
1,212
1,290
4,968
7,416
5,887
5,887
91
28
55
55
49
794
66
192
75
75
82
82
73
73
84
84
242
242
305
305
469
469
46946930530524224284847373828275751926679449555528915,8875,8877,4164,9681,2901,212243243142142234234128128402402434343433131137137637637535367677676414113813816516517317327271281281550111731736246249119118708642,1532,15351450912912992691441440000000
       Other Current Assets 
0
0
0
0
0
44
44
50
50
153
153
54
54
117
117
369
369
157
157
151
151
78
78
61
61
9
9
0
17
6
6
53
53
28
28
73
73
1
1
16
16
2
2
18
18
2
2
21
21
2
2
23
23
2
3
21
21
2
2
30
30
10
10
74
74
54
54
45
48
72
108
53
53
29,843
44,343
63
63
745
69
126
101
105
105
967
967
0
91
0
0
155
155
0
111
0
254
254011101551550091096796710510510112669745636344,34329,843535310872484554547474101030302221213223232221212218182216161173732828535366170996161787815115115715736936911711754541531535050444400000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
5,058
0
0
0
2,799
0
0
0
1,720
0
0
0
868
0
0
0
190
0
0
0
481
0
0
0
476
0
0
0
212
0
0
0
302
0
0
0
242
0
0
0
282
0
0
0
283
0
0
0
251
0
0
0
353
0
0
0
540
0
0
0
36,234
0
0
0
381
0
0
0
279
0
0
0
312
0
0
0
531
0
0
0
1,886
0
0
0
4,438
4,4380001,88600053100031200027900038100036,2340005400003530002510002830002820002420003020002120004760004810001900008680001,7200002,7990005,0580000000000
       Property Plant Equipment 
0
0
0
0
0
292
292
564
564
965
4,438
1,604
1,604
1,074
2,277
1,277
1,277
1,273
1,273
944
944
737
737
222
222
123
123
0
589
481
481
360
360
476
476
395
395
212
212
340
340
302
302
276
276
242
242
269
269
282
282
290
290
283
283
294
294
251
251
321
321
353
353
594
594
540
540
382
406
15,374
22,950
14,917
14,917
256
381
313
313
279
279
389
389
312
312
735
735
531
531
472
472
1,886
1,886
2,975
2,975
4,015
4,015
4,0154,0152,9752,9751,8861,88647247253153173573531231238938927927931331338125614,91714,91722,95015,37440638254054059459435335332132125125129429428328329029028228226926924224227627630230234034021221239539547647636036048148158901231232222227377379449441,2731,2731,2771,2772,2771,0741,6041,6044,43896556456429229200000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,649
9,925
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000009,9256,649000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000005500000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
216
216
1,035
1,035
383
619
438
438
456
522
516
516
447
447
449
449
131
131
129
129
67
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,894
3,351
8,894
8,894
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000008,8948,8943,3518,89400000000000000000000000000000000000000000067671291291311314494494474475165165224564384386193831,0351,03521621600000
       Other Assets 
0
0
0
0
0
1,773
1,773
2,655
2,655
4,093
4,093
6,031
6,031
1,725
1,725
1,996
1,996
447
447
449
449
131
131
129
129
67
67
0
1,071
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,899
8,899
9,030
9,030
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
656
656
423
423
4234236566560000000000000000009,0309,0308,8998,89900000000000000000000000000000000000000001,071067671291291311314494494474471,9961,9961,7251,7256,0316,0314,0934,0932,6552,6551,7731,77300000
> Total Liabilities 
0
0
0
0
0
618
618
808
808
1,328
1,328
2,140
2,140
1,598
1,598
1,317
1,317
1,582
1,582
1,444
1,444
1,327
1,327
309
309
205
205
0
277
317
317
381
381
409
409
405
405
462
462
273
273
300
300
259
259
329
329
348
348
394
394
486
486
439
439
382
382
500
500
574
574
566
566
658
658
696
696
736
783
25,921
38,693
27,734
27,734
26,052
38,711
568
568
468
468
448
448
533
533
798
798
0
700
0
823
0
2,561
0
2,241
0
2,909
2,90902,24102,56108230700079879853353344844846846856856838,71126,05227,73427,73438,69325,92178373669669665865856656657457450050038238243943948648639439434834832932925925930030027327346246240540540940938138131731727702052053093091,3271,3271,4441,4441,5821,5821,3171,3171,5981,5982,1402,1401,3281,32880880861861800000
   > Total Current Liabilities 
0
0
0
0
0
593
593
725
725
1,156
1,156
1,961
1,961
1,435
1,435
1,121
1,121
1,443
1,443
1,353
1,353
1,272
1,272
309
309
205
205
0
277
317
317
381
381
409
409
405
405
462
462
273
273
300
300
259
259
329
329
348
348
394
394
486
486
439
439
382
382
439
500
574
574
483
483
582
582
602
602
676
719
11,510
17,182
13,229
13,229
26,028
38,675
553
553
450
450
275
275
347
347
619
619
623
623
794
794
1,084
1,084
835
835
1,616
1,616
1,6161,6168358351,0841,08479479462362361961934734727527545045055355338,67526,02813,22913,22917,18211,51071967660260258258248348357457450043938238243943948648639439434834832932925925930030027327346246240540540940938138131731727702052053093091,2721,2721,3531,3531,4431,4431,1211,1211,4351,4351,9611,9611,1561,15672572559359300000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91
0
0
0
115
0
0
0
37
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,242
0
0
561
561
0
0
0
0
0
0
0
0
0
0
0
135
0
0
0
277
0
0
0
258
258000277000135000000000005615610011,24200000000000000000000000000000000000000000003700011500091000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
561
561
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005615610000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
234
234
641
641
723
723
0
0
351
351
0
0
699
699
0
0
629
629
0
0
58
58
0
245
71
71
300
300
35
35
0
0
102
102
0
0
33
33
0
0
72
72
0
0
48
48
0
0
90
90
0
0
144
144
0
0
165
165
0
0
227
227
0
0
2,092
2,092
2,698
2,698
247
247
368
368
153
153
184
184
130
130
205
205
61
61
398
398
390
390
249
249
704
704
70470424924939039039839861612052051301301841841531533683682472472,6982,6982,0922,092002272270016516500144144009090004848007272003333001021020035353003007171245058580062962900699699003513510072372364164123423400000
       Other Current Liabilities 
0
0
0
0
0
348
348
45
45
385
433
1,738
1,738
894
1,084
1,022
1,022
654
653
1,260
1,260
528
528
250
250
110
110
0
33
246
246
81
81
374
374
405
405
360
360
274
274
267
267
259
259
256
257
347
347
346
346
485
485
348
349
382
382
294
355
574
574
319
318
582
582
375
374
675
719
7,241
2,817
10,531
10,531
25,219
38,308
184
184
128
297
91
91
105
218
165
165
273
427
388
388
174
417
336
336
199
655
655199336336417174388388427273165165218105919129712818418438,30825,21910,53110,5312,8177,24171967537437558258231831957457435529438238234934848548534634634734725725625925926726727427436036040540537437481812462463301101102502505285281,2601,2606536541,0221,0221,0848941,7381,738433385454534834800000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
172
0
0
0
164
0
0
0
138
0
0
0
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83
0
0
0
95
0
0
0
21,511
0
0
0
36
0
0
0
18
0
0
0
185
0
0
0
77
0
0
0
1,477
0
0
0
1,293
1,2930001,47700077000185000180003600021,5110009500083000000000000000000000000000000000000000550001380001640001720000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
0
0
0
0
0
1,005
0
913
0
776
776091301,005000008000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
0
0
0
0
32
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60
60
0
0
83
83
77
77
95
95
60
64
6,704
6,704
10,238
10,238
24
24
15
15
18
18
172
172
185
185
171
171
77
77
29
29
472
472
493
493
517
517
5175174934934724722929777717117118518517217218181515242410,23810,2386,7046,704646095957777838300606000000000000000000000000000000000003232000077770000000000000
> Total Stockholder Equity
0
0
0
0
0
7,315
7,315
6,686
6,686
10,199
10,199
13,310
13,310
6,373
6,373
6,762
6,762
3,456
3,456
3,841
3,841
2,108
2,108
1,414
1,414
527
527
0
4,168
1,592
1,592
1,071
1,071
1,550
1,550
905
905
3,010
3,010
1,840
1,840
1,033
1,033
1,167
1,167
1,394
1,394
2,174
2,174
6,891
6,891
5,386
5,386
4,773
4,773
4,173
4,173
2,776
2,776
7,381
7,381
7,101
7,101
7,003
7,003
5,347
5,347
5,274
5,614
9,315
13,906
7,948
7,948
4,781
7,103
4,782
4,782
4,002
4,002
2,535
2,535
4,235
4,235
3,178
3,178
0
3,209
0
6,167
0
21,114
0
18,420
0
12,355
12,355018,420021,11406,16703,20903,1783,1784,2354,2352,5352,5354,0024,0024,7824,7827,1034,7817,9487,94813,9069,3155,6145,2745,3475,3477,0037,0037,1017,1017,3817,3812,7762,7764,1734,1734,7734,7735,3865,3866,8916,8912,1742,1741,3941,3941,1671,1671,0331,0331,8401,8403,0103,0109059051,5501,5501,0711,0711,5921,5924,16805275271,4141,4142,1082,1083,8413,8413,4563,4566,7626,7626,3736,37313,31013,31010,19910,1996,6866,6867,3157,31500000
   Common Stock
0
0
0
0
0
7,883
7,883
7,882
7,882
12,169
12,169
17,503
17,503
17,506
17,506
17,506
17,506
17,535
17,535
19,068
19,068
19,063
19,063
19,063
19,063
19,126
19,126
0
16,593
16,559
16,746
16,559
16,559
16,859
16,859
16,859
16,859
21,467
21,536
21,467
21,467
21,467
21,467
22,669
22,669
24,082
24,153
25,811
25,811
31,750
31,859
31,750
31,750
31,808
32,121
31,913
31,913
31,969
31,969
37,122
37,122
38,658
38,658
39,610
39,610
40,610
40,610
29,407
31,302
36,961
55,175
38,790
38,790
40,444
60,095
59,062
59,062
59,062
59,062
59,181
59,181
62,421
62,421
62,458
62,458
64,292
64,292
68,137
68,137
86,209
86,209
87,041
87,041
87,454
87,454
87,45487,45487,04187,04186,20986,20968,13768,13764,29264,29262,45862,45862,42162,42159,18159,18159,06259,06259,06259,06260,09540,44438,79038,79055,17536,96131,30229,40740,61040,61039,61039,61038,65838,65837,12237,12231,96931,96931,91331,91332,12131,80831,75031,75031,85931,75025,81125,81124,15324,08222,66922,66921,46721,46721,46721,46721,53621,46716,85916,85916,85916,85916,55916,55916,74616,55916,593019,12619,12619,06319,06319,06319,06319,06819,06817,53517,53517,50617,50617,50617,50617,50317,50312,16912,1697,8827,8827,8837,88300000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-188
0
0
0
-358
0
0
0
-708
0
0
0
-1,022
0
0
0
-747
0
0
0
-1,129
0
0
0
212
0
0
0
-1,322
0
0
0
70
0
0
0
-1,413
0
0
0
-1,404
0
0
0
-1,512
0
0
0
329
0
0
0
456
0
0
0
968
0
0
0
508
0
0
0
1,313
0
0
0
788
0
0
0
170
0
0
0
347
0
0
0
2,550
0
0
0
3,263
3,2630002,5500003470001700007880001,313000508000968000456000329000-1,512000-1,404000-1,41300070000-1,322000212000-1,129000-747000-1,022000-708000-358000-1880000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
188
0
0
0
358
0
0
0
708
0
0
0
1,022
0
0
0
747
0
0
0
1,129
0
0
0
2,720
0
0
0
1,322
0
0
0
1,476
0
0
0
1,413
0
0
0
1,404
0
0
0
1,512
0
0
0
1,808
0
0
0
2,039
0
0
0
2,713
0
0
0
4,891
444
444
882
3,195
869
869
788
2,795
19
19
170
2,331
130
130
347
2,363
926
926
2,550
2,550
2,845
2,845
3,263
3,263
3,2633,2632,8452,8452,5502,5509269262,3633471301302,33117019192,7957888698693,1958824444444,8910002,7130002,0390001,8080001,5120001,4040001,4130001,4760001,3220002,7200001,1290007470001,0220007080003580001880000000000



Balance Sheet

Currency in EUR. All numbers in thousands.